These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema.
    Author: Shaw C, Mortimer P, Judd PA.
    Journal: Cancer; 2007 Oct 15; 110(8):1868-74. PubMed ID: 17823909.
    Abstract:
    BACKGROUND: Obesity is considered a risk factor for the development of breast cancer-related lymphedema of the arm and as a poor prognostic factor in response to lymphedema treatment. The objective of this study was to examine weight reduction as a treatment for breast cancer-related lymphedema. METHODS: Twenty-one women with breast cancer-related lymphedema were randomized either to receive dietary advice for weight reduction or to receive a booklet on general healthy eating. They were monitored for 12 weeks. RESULTS: The primary outcome measure was arm volume at 12 weeks. The results indicated a significant reduction in swollen arm volume at the end of the 12-week period (P = .003) in the intervention weight-reduction group. There was a significant reduction in body weight (P = .02) and body mass index (P = .016) in the weight-reduction group at the end of the 12-week study period. CONCLUSIONS: Weight loss achieved by dietary advice to reduce energy intake can reduce breast cancer-related lymphedema significantly.
    [Abstract] [Full Text] [Related] [New Search]